miRNA regulated genes and pathways as targets for therapeutic intervention

Details for Australian Patent Application No. 2007333110 (hide)

Owner Asuragen, Inc. Yale University

Inventors Johnson, Charles D.; Brown, David; Bader, Andreas G.; Byrom, Mike

Agent Pizzeys

Pub. Number AU-A-2007333110

PCT Pub. Number WO2008/073923

Priority 60/882,758 29.12.06 US; 60/869,295 08.12.06 US

Filing date 10 December 2007

Wipo publication date 19 June 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

9 July 2009 PCT application entered the National Phase

  PCT publication WO2008/073923 Priority application(s): WO2008/073923

13 August 2009 Alteration of Name

  The name of the applicant has been altered to Asuragen, Inc.

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007333115-Composition for treating a pulmonary hypertension

2007333109-Functions and targets of let-7 micro RNAs